Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin + vonoprazan dual therapy dosing for H. pylori eradication
ChiCTR2200064874Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin and vonoprazan in Helicobacter pylori infection (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Helicobacter pylori eradication rate. Started Dec 2021; status: recruiting.
02
Drugs
amoxicillinvonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200064874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064874.